Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 22, 2010 - Issue 2
191
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Effects of metal compounds with distinct physicochemical properties on iron homeostasis and antibacterial activity in the lungs: chromium and vanadium

, , , , , , , , , & show all
Pages 169-178 | Received 27 May 2009, Accepted 04 Jul 2009, Published online: 18 Jan 2010

References

  • Ani M, Moshtaghie AA. 1992. The effect of chromium on parameters related to iron metabolism. Biol Trace Elem Res 32:57–64.
  • Barac-Nieto M, Alfred M, Spitzer A. 2002. Basolateral phosphate transport in renal proximal tubule-like OK cells. Exp Biol Med 227:626–631.
  • Baran EJ. 2000. Oxovanadium(IV) and oxovanadium(V) complexes relevant to biological systems. J Inorg Biochem 80:1–10.
  • Bell JM, Philp JC, Kuyukina MS, Ivshina IB, Dunbar SA, Cunningham CJ, Anderson P. 2004. Methods evaluating vanadium tolerance in bacteria isolated from crude oil contaminated land. J Micro Methods 58:87–100.
  • Chien PS, Mak OT, Huang HJ. 2006. Induction of COX-2 protein expression by vanadate in A549 human lung carcinoma cell line through EGF receptor and p38 MAPK-mediated pathway. Biochem Biophys Res Commun 339:562–568.
  • Clodfelder BJ, Emamaullee J, Hepburn DD, Chakov NE, Nettles HS, Vincent JB. 2001. The trail of chromium(III) in vivo from the blood to the urine: The roles of transferrin and chromodulin. J Biol Inorg Chem 6:608–617.
  • Cohen MD. 2000. Other metals: Aluminum copper manganese selenium vanadium and zinc. In: Cohen MD, Zelikoff JT, Schlesinger RB, eds. Pulmonary Immunotoxicology. Norwell MA: Kluwer Academic Publishers, 267–300.
  • Cohen MD. 2004. Pulmonary immunotoxicology of select metals: Aluminum arsenic cadmium chromium copper manganese nickel vanadium and zinc. J Immunotoxicol 1:39–70.
  • Cohen MD. 2005. Pulmonary immunotoxicology. In: Gardner D, ed. Toxicology of the Lung. 4th ed. Boca Raton, FL: Taylor and Francis/CRC Press, 351–420.
  • Cohen MD, Chen L C, Zelikoff J T, Schlesinger R B. 1997. Pulmonary retention and distribution of inhaled chromium: Effects of particle solubility and ozone co-exposure. Inhal Toxicol 9:843–865.
  • Cohen MD, Prophete C, Sisco M, Chen L, Zelikoff J, Smee J, Holder A, Crans D. 2006. Pulmonary immunotoxic potentials of metals are governed by select physicochemical properties: Chromium agents. J Immunotoxicol 3: 69–81.
  • Cohen MD, Schook LB, Oppenheim JJ, Freed BM, Rodgers KE. 1999. Alterations in cytokine receptors by xenobiotics. Toxicol Sci 48:163–169.
  • Cohen MD, Sisco M, Baker K, Li Y, Lawrence D, van Loveren H, Zelikoff J T, Schlesinger RB. 2002. Effect of inhaled ozone on pulmonary immune cells critical to antibacterial responses in situ. Inhal Toxicol 14:599–619.
  • Cohen MD, Sisco M, Prophete C, Chen L, Zelikoff JT, Smee JJ, Holder AA, Ghio AJ, Stonehuerner JD, Crans DC. 2007. Pulmonary immunotoxic potentials of metals are governed by select physicochemical properties: Vanadium agents. J Immunotoxicol 4:49–60.
  • Cohen MD, Yang Z, Qu Q, Schlesinger RB, Zelikoff JT. 1996. Vanadium affects macrophage interferon-γ-binding and -inducible responses. Toxicol Appl Pharmacol 138:110–120.
  • Cohen MD, Yang Z, Zelikoff JT. 1994. Immunotoxicity of particulate lead: In vitro exposure alters pulmonary macrophage tumor necrosis factor-α release and activity. J Toxicol Environ Health 42:377–392.
  • Cohen MD, Zelikoff JT, Chen LC, Schlesinger RB. 1998. Immunotoxicologic effects of inhaled chromium: Role of particle solubility and co-exposure to ozone. Toxicol Appl Pharmacol 152:30–40.
  • Crans DC, Smee JJ, Gaidamauskas E, Yang L. 2004. The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds. Chem Rev 104:849–902.
  • Dean JA, ed. 1999. Lange’s Handbook of Chemistry. 15th ed. New York: McGraw Hill, 322.
  • Doherty SP, Prophete C, Maciejczyk P, Salnikow K, Gould T, Larson T, Koenig J, Jaques P, Sioutas C, Zelikoff J, Lippmann M, Cohen MD. 2007. Detection of changes in alveolar macrophage iron status induced by select PM25-associated components using iron response protein binding activity. Inhal Toxicol 19:553–562.
  • Elmariah S, Gunn RB. 2003. Kinetic evidence that the Na-PO4 co-transporter is the molecular mechanism for Na/Li exchange in human red blood cells. Am J Physiol Cell Physiol 285: C446–C456.
  • Ghio AJ, Carter JD, Dailey LA, Devlin RB, Samet JM. 1999. Respiratory epithelial cells demonstrate lactoferrin receptors that increase after metal exposure. Am J Physiol 276: L933–L940.
  • Ghio AJ, Cohen MD. 2005. Disruption of iron homeostasis as a mechanism of biologic effect by particles. Inhal Toxicol 17:709–716.
  • Harrington JP. 1992. Spectroscopic analysis of the unfolding of transition metal-ion complexes of human lactoferrin and transferring. Int J Biochem 24:275–280.
  • Harris DC. 1977. Different metal-binding properties of the two sites of human transferring. Biochemistry 16:560–564.
  • Jeong HJ, Chung HS, Lee BR, Kim SJ, Yoo SJ, Hong SH, Kim HM. 2003. Expression of pro-inflammatory cytokines via HIF-1α and NF-κB activation on desferrioxamine-stimulated HMC-1 cells. Biochem Biophys Res Commun 306:805–811.
  • Jeong HJ, Hong SH, Park RK, Shin T, An NH, Kim HM. 2005. Hypoxia-induced IL-6 production is associated with activation of MAP kinase HIF-1 and NF-κB on HEI-OC1 cells. Hearing Res 207:59–67.
  • Katz SA, Salem H. 1993. The toxicology of chromium with respect to its chemical speciation: A review. J Appl Toxicol 13:217–224.
  • Lay PA, Levina A. 2004. Chromium. In: McCleverty JA, Meyer TJ, eds. Comprehensive Coordination Chemistry II—From Biology and Nanotechnology. Volume 4 Transition Metal Groups 3–6. San Diego, CA: Elsevier Pergamon, 313–413.
  • Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW. 2004. Hypoxia-inducible factor. HIF-1α: Its protein stability and biological functions. Exp Mol Med 36:1–12.
  • Liochev SI, Fridovich I. 1990. Vanadate-stimulated oxidation of NAD(P)H in the presence of biological membranes and other sources of O2−. Arch Biochem Biophys 279:1–7.
  • Mazurier J, L’Hoste J, Montreuil J, Spik G. 1983. Comparative study of the iron-binding properties of human transferrins. II. Electron paramagnetic resonance of mixed-metal complexes of human lactotransferrin. Biochim Biophys Acta 745:44–49.
  • McCleverty JA, Meyer TJ, Editors. 2004. Comprehensive Coordination Chemistry II—From Biology and Nanotechnology. Volume 4. Transition Metal Groups 3–6. San Diego, CA: Elsevier Pergamon.
  • Moshtaghie AA, Ani M, Bazrafshan MR. 1992. Comparative binding study of aluminum and chromium to human transferring. Effect of iron. Biol Trace Elem Res 32:39–46.
  • Nag K, Bose SN. 1985. Chemistry of tetra- and pentavalent chromium. Struct Bond 63:153–197.
  • Nagaoka MH, Yamazaki T, Maitani T. 2002. Binding patterns of vanadium ions with different valence states to human serum transferrin studied by HPLC/high-resolution ICP-MS. Biochem Biophys Res Commun 296:1207–1214.
  • Nechay BR, Nanninga LB, Nechay PS. 1986. Vanadyl (IV) and vanadate (V) binding to selected endogenous phosphate, carboxyl, and amino ligands; calculations of cellular vanadium species distribution. Arch Biochem Biophys 251:128–138.
  • NTP National Toxicology Program. 2002. NTP Toxicology and Carcinogenesis Studies of Vanadium Pentoxide (CAS No. 1314-62-1) in F344/N Rats and B6C3F1 Mice (Inhalation). National Toxicology Program Technical Report Series. 507:1–343.
  • Prophete C, Maciejczyk P, Salnikow K, Gould T, Larson T, Koenig J, Jaques P, Sioutas C, Lippmann M, Cohen MD. 2006. Effects of PM-associated metals on alveolar macrophage phosphorylated ERK-1 and -2 and iNOS expression during ongoing alteration in iron homeostasis. J Toxicol Environ Health 69:935–951.
  • Rehder D. 1992. Inorganic considerations on the function of vanadium in biological systems. In: Sigel H, Sigel A, eds. Metal Ions in Biological Systems. Vol. 31. Vanadium and Its Role in Life. New York: Marcel Dekker, 1–44.
  • Riley MR, Boesewetter DE, Kim AM, Sirvent FP. 2003. Effects of metals, Cu, Fe, Ni, V, and Zn, on rat lung epithelial cells. Toxicology 190:171–184.
  • Sigel H, Sigel A, eds. 1992. Metal Ions in Biological Systems. Vol 31. Vanadium and Its Role in Life. New York: Marcel Dekker.
  • Standeven AM, Wetterhahn KE. 1989. Chromium(VI) toxicity: Uptake reduction and DNA damage. J Am Coll Toxicol 8:1275–1283.
  • Stern A, Davison AJ, Wu Q, Moon J. 1992. Effects of ligands on reduction of oxygen by vanadium(IV) and vanadium(III). Arch Biochem Biophys 299:125–128.
  • Tanaka A. 2004. Toxicity of indium arsenide gallium arsenide and aluminium gallium arsenide. Toxicol Appl Pharmacol 198:405–411.
  • Wang L, Medan D, Mercer R, Shi X, Huang C, Castranova V, Ding M, Rojanasakul Y. 2002. Role of neutrophil apoptosis in vanadium-induced pulmonary inflammation in mice. J Environ Pathol Toxicol Oncol 21:343–350.
  • Ward RJ, Wilmet S, Legssyer R, Crichton RR. 2002. The influence of iron homoeostasis on macrophage function. Biochem Soc Trans 30:762–765.
  • Willsky GR, Goldfine AB, Kostyniak PJ, McNeill JH, Yang L, Khan AR, Crans DC. 2001. Effect of vanadium (IV) compounds in the treatment of diabetes: In vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV). J Inorg Biochem 85:33–42.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.